Covid-19 vaccine SA trials; ample Aspen Covid drugs; SAA
South Africa is starting Covid-19 vaccine trials and Aspen can manufacture enough dexamethasone to cope with a huge number of Covid-19 cases.
South Africa is starting Covid-19 vaccine trials and Aspen can manufacture enough dexamethasone to cope with a huge number of Covid-19 cases.
Aspen group senior executive Stavros Nicolaou shares details of what is known about Covid-19 life-saving drug Dexamethasone and supply arrangements with BizNews founder Alec Hogg.
Although Covid-19 cases are rising sharply, South Africa is set to lift some lockdown restrictions soon to ease the economic burden and curb job losses.
The best of BizNews Radio takes a critical worldview of Eskom’s finances with Nick Smith-Saville from Debtwire. David Shapiro invokes Warren Buffett’s analogy of a cockroach as he examines companies in trouble. And more…
In this week’s edition of Rational Radio, SA’s favourite market commentator David Shapiro wades into the investment market controversies surrounding Discovery, Sasol, Blue Label and Aspen.
Moody hasn’t said it, but investors already think it: South Africa’s credit is junk. That’s according to Bloomberg, which says the market is pricing in a downgrade.
More dirty laundry will be publicly aired today when Dan Matjila, the former chief executive of South Africa’s Public Investment Corporation, takes the stand at the PIC Commission of Inquiry.
Telkom’s share price jumped nearly 14% to an all-time high of just over R98 per share after it released its Group Provisional Annual Results.
Last week’s ousting of Sudan’s supposed president for life, 75-year-old Omar al-Bashir, is ushering in a raft of new democratic freedoms.
Aspen Pharmacare shares plunged to a seven-year low as an already protracted deal to sell its infant-formula business dragged out even further, choking off cash flows and weighing on financing costs.